Venus has metamorphosed to feature among the leaders providing innovative solutions to unmet medical needs with its high-tech medicine research facility. Our medicine research centre equipped with high-tech infrastructure and capable professionals makes us one of the best pharmaceutical organizations in terms of developing research-based medicine.
Research projects of Venus are never limited to a single field in the pharmaceutical industry. We conquered multiple fields from Antimicrobial Resistance (AMR), to Oncology and from skin & wound care to pain management. Our medicine research capabilities have helped us and our clients achieve huge success in the market with research-based medicines in multiple branches.
We are leading the pharmaceutical market with multiple products such as TROIS, AMPUCARE, and ELORES in Germany and multiple other countries. All these products are researched by Venus and patented in multiple regions all over the globe.
The Company has the right blend of the spectrum, vision, talent, and capabilities that enable us to actualize our goals and achieve success in the market with research-based medicines.
Our GLP accredited Venus Medicine Research Centre (VMRC) is committed to bringing to the world novel breakthroughs that cater to critical care and super specialty segments.